SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-171921
Filing Date
2022-06-10
Accepted
2022-06-10 16:01:59
Documents
13
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d370247d8k.htm   iXBRL 8-K 36134
  Complete submission text file 0001193125-22-171921.txt   189509

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cue-20220609.xsd EX-101.SCH 3241
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20220609_def.xml EX-101.DEF 13371
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20220609_lab.xml EX-101.LAB 21915
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20220609_pre.xml EX-101.PRE 14168
7 EXTRACTED XBRL INSTANCE DOCUMENT d370247d8k_htm.xml XML 4762
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 221008794
SIC: 2834 Pharmaceutical Preparations